financetom
Market
financetom
/
Market
/
PB Fintech to invest a sum of ₹350 crore in wholly-owned subsidiary Policybazaar
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
PB Fintech to invest a sum of ₹350 crore in wholly-owned subsidiary Policybazaar
Nov 27, 2023 1:11 AM

PB Fintech Ltd., a financial services platform has invested an additional sum of ₹350 crore in its wholly-owned subsidiary Policybazaar Insurance Brokers Pvt. Ltd.

Share Market Live

NSE

The investment in the Gurugram-based subsidiary was done at an arm's length basis, the company said in an exchange filing.

PB Fintech said that the current investment will allow Policybazaar to strengthen its financial health, meet general operating expenses and enhance brand awareness, office presence and strategic initiatives.

The funds will be infused in one or more tranches across financial year 2024 and 2025. The investment has been made at a price of ₹603 apiece, post which, 58 lakh shares of Policybazaar have been allotted to the parent company.

In December 2021, PB Fintech had announced that it will invest up to ₹700 crore in Policybazaar in one or more tranches during financial year 2022 and 2023. It also announced an investment of ₹230 crore in Paisabazaar Marketing and Consulting Pvt. Ltd., a digital marketplace for consumer credit.

In a clarification issued to the exchanges on September 11, PB Fintech mentioned that it has no intentions of becoming a direct insurer or applying for such a license, emphasising its commitment to maintaining a harmonious relationship with existing insurance partners.

CNBC-TV18 had reported that PB Fintech is looking at bringing some significant diversification into its business lines.

Having listed two years earlier in November 2021, PB Fintech's shares are trading close to their 52-week high of ₹846.5, but continue to remain below its issue price of ₹980.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
US Health Insurance Stocks Fall After Centene Withdraws 2025 EPS Guidance
US Health Insurance Stocks Fall After Centene Withdraws 2025 EPS Guidance
Jul 2, 2025
12:01 PM EDT, 07/02/2025 (MT Newswires) -- Health insurance stocks were down in recent Wednesday trading after Centene ( CNC ) withdrew its full-year earnings outlook. Molina Healthcare ( MOH ) shares were falling over 20%, UnitedHealth Group ( UNH ) was down 3.4%, Elevance Health ( ELV ) was down 8%, Humana (HUM) was down 2.8% and CVS Health...
US Equity Indexes Mixed in Midday Trading
US Equity Indexes Mixed in Midday Trading
Jul 2, 2025
12:26 PM EDT, 07/02/2025 (MT Newswires) -- US equity indexes and government bond yields traded mixed after midday on Wednesday as investors weighed the labor market data. The Nasdaq rose 0.9% to 20,375.9 after hitting an all-time high of 20,418.31 on Monday. The S&P 500 climbed 0.3% to 6,215.5, trading beneath its new peak of 6,217.48 scaled before midday on...
US STOCKS-Wall St recovers with help from Nvidia, Tesla; jobs data awaited
US STOCKS-Wall St recovers with help from Nvidia, Tesla; jobs data awaited
Jul 2, 2025
* S&P 500 up 0.3%, Nasdaq up 0.75%, Dow flat * US private payrolls decrease unexpectedly in June * Centene ( CNC ) tumbles after pulling 2025 forecast * Tesla climbs after Q2 deliveries report (Updates with early afternoon price) By Sruthi Shankar and Nikhil Sharma July 2 (Reuters) - U.S. stocks recovered from opening losses to trade higher on...
Sector Update: Health Care
Sector Update: Health Care
Jul 2, 2025
01:05 PM EDT, 07/02/2025 (MT Newswires) -- Health care stocks fell Wednesday afternoon, with the NYSE Health Care Index shedding 0.9% and the Health Care Select Sector SPDR Fund (XLV) down 0.8%. The iShares Biotechnology ETF (IBB) was rising 1.2%. In corporate news, Centene's ( CNC ) shares sank over 39% after the company withdrew its full-year earnings outlook, citing...
Copyright 2023-2026 - www.financetom.com All Rights Reserved